The AASLD is hosting an event focused on the latest developments in the treatment of NASH (nonalcoholic steatohepatitis) and NASH cirrhosis. Attendees will have the opportunity to learn about new mechanisms for reversing fibrosis in patients with NASH, as well as new therapeutic agents being developed to treat NASH cirrhosis. The event will also cover updates on clinical trials and regulatory science in the field. By the end of the event, attendees should have a better understanding of the current state of the art in the treatment of NASH and NASH cirrhosis and be able to incorporate this knowledge into their practice.
Date: Saturday, March 25, 10:00 am – Sunday, March 26, 4:30 pm (EDT)
Location: JW Marriott Los Angeles L.A. Live | 900 West Olympic Boulevard | Los Angeles, CA 90015
